Pharma-funded CME falls off again; Bayer may boost dividend, CFO says;

 @FiercePharma: Chinese officials arrest 2,000 (brave, foolhardy, daft, choose your adjective) people in counterfeit-drug sting. News | Follow @FiercePharma

> Pharma-backed continuing medical education has taken another plunge; according to recent figures, industry funding dropped 11.4% to $736 million last year. Report

> Bayer may raise its dividend if its adjusted earnings rise 10% as expected, CFO Werner Baumann told the newspaper Frankfurter Allgemaine Sonntagszeitung. Report

> Mylan ($MYL) has inaugurated commercial operations in India with the launch of 18 anti-HIV drugs, looking for "significant growth" in that market. Report

> Chinese police picked up almost 2,000 people in a counterfeit drug sting, seizing more than $180 million in fake drugs and destroying more than 1,000 production facilities. Report

> Alliance Pharma is making its first big foray into the European market, after acquiring three antimalarial drug brands from AstraZeneca ($AZN). Report

> Biostar Pharmaceuticals won the all-clear from Chinese regulators to restart production of its gel capsule products, after tainted gel capsules surfaced countrywide in April. Report

Biotech News

 @FierceBiotech: Teva's MLK inhibitor blocks aggressive breast cancer in MSU study. Article | Follow @FierceBiotech

 @JohnCFierce: There's no question that AZ paid too much for MedImmune. The question now is whether MedImmune has built a valuable pipeline. More | Follow @JohnCFierce

 @RyanMFierce: Did the VCs get dissed again? Novartis backs UPenn's pioneering cancer immunotherapies. Article | Follow @RyanMFierce

> Industry Voices: Microbiome Therapies - Coming to a Clinic Near You. More

> Astellas Pharma axes Durham R&D site amid generics threat. News

> K-V Pharma travels bankruptcy route after suing FDA. Story

> FDA approves Sanofi's Zaltrap for colorectal cancer. More

Medical Device News

@FierceMedDev: Cleveland Heart will use $30M in new investment to advance its artificial heart device. An LVAD is also in the mix. News | Follow @FierceMedDev

 @MarkHFierce: Doctors in Japan have implanted the first baby there with an artificial heart. Release | Follow @MarkHFierce

 @DamianFierce: Covidien is voluntarily recalling two models of tracheostomy tubes over leakage risks. Report | Follow @DamianFierce

> Cleveland Heart draws $30M from Korean equity group. More

> CardioNet grabs cardiac testing lab for $23.5M. News

> Globus Medical IPO pulls in $100M in the face of lowered expectations. Item

Biotech IT News

> Bayer boosts diabetes message with new blog. Story

> Accenture snaps up pharma software outfit Octagon. Article

> Qsymia approval process. Timeline

> AstraZeneca adopts search engine for scientists. More

> Medidata lands record $100M deal with a Big Pharma. Story

CRO News

> Accenture boosts clinical data offerings with Octagon buy. Article

> Halo buys Teva's Canadian plant, inks production deal. News

> Report: Weak rupee hampers Indian CRO sales. More

> House Dems look to boost trial safety for patients. Story

And Finally... Jiminy Cricket knew what he was talking about: Telling the truth is healthier than lying. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.